It depends on which medication and format you use. DirectMeds' flat $147 is a high price for some patients and a low one for others, so a single list of alternatives does not help. Instead, here are three separate answers:
- Semaglutide patients are overpaying and have five cheaper options.
- Tirzepatide patients are already getting a good price and have only two cheaper options.
- Drops patients have no direct alternative, so staying makes sense, with conditions.








